Nanomolar oxytocin synergizes with weak electrical afferent stimulation to activate the locomotor CPG of the rat spinal cord in vitro. by Dose, F. et al.
Nanomolar Oxytocin Synergizes with Weak Electrical
Afferent Stimulation to Activate the Locomotor CPG of
the Rat Spinal Cord In Vitro
Francesco Dose1,2, Patrizia Zanon1,2, Tamara Coslovich1,2, Giuliano Taccola1,2*
1Neuroscience Department, International School for Advanced Studies (S.I.S.S.A.), Trieste, Italy, 2 Spinal Person Injury Neurorehabilitation Applied Laboratory (S.P.I.N.A.L.),
Istituto di Medicina Fisica e Riabilitazione (IMFR), Udine, Italy
Abstract
Synergizing the effect of afferent fibre stimulation with pharmacological interventions is a desirable goal to trigger spinal
locomotor activity, especially after injury. Thus, to better understand the mechanisms to optimize this process, we studied
the role of the neuropeptide oxytocin (previously shown to stimulate locomotor networks) on network and motoneuron
properties using the isolated neonatal rat spinal cord. On motoneurons oxytocin (1 nM–1 mM) generated sporadic bursts
with superimposed firing and dose-dependent depolarization. No desensitization was observed despite repeated
applications. Tetrodotoxin completely blocked the effects of oxytocin, demonstrating the network origin of the responses.
Recording motoneuron pool activity from lumbar ventral roots showed oxytocin mediated depolarization with synchronous
bursts, and depression of reflex responses in a stimulus and peptide-concentration dependent fashion. Disinhibited bursting
caused by strychnine and bicuculline was accelerated by oxytocin whose action was blocked by the oxytocin antagonist
atosiban. Fictive locomotion appeared when subthreshold concentrations of NMDA plus 5HT were coapplied with oxytocin,
an effect prevented after 24 h incubation with the inhibitor of 5HT synthesis, PCPA. When fictive locomotion was fully
manifested, oxytocin did not change periodicity, although cycle amplitude became smaller. A novel protocol of electrical
stimulation based on noisy waveforms and applied to one dorsal root evoked stereotypic fictive locomotion. Whenever the
stimulus intensity was subthreshold, low doses of oxytocin triggered fictive locomotion although oxytocin per se did not
affect primary afferent depolarization evoked by dorsal root pulses. Among the several functional targets for the action of
oxytocin at lumbar spinal cord level, the present results highlight how small concentrations of this peptide could bring
spinal networks to threshold for fictive locomotion in combination with other protocols, and delineate the use of oxytocin
to strengthen the efficiency of electrical stimulation to activate locomotor circuits.
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Introduction
It is well known that the thoraco-lumbar spinal cord of
mammals contains the neuronal hardware, indicated as central
pattern generator (CPG), required to express the basic program
that drives the alternated activation of flexor and extensor limb
muscles during gait [1,2]. The locomotor output is already present
at birth and depends on the biophysical properties of motoneurons
and interneurons composing the CPG, as well as on the
connectivity among the elements of the network [3].
Neuromodulatory substances sculpt the rhythmic CPG pattern
and confer the necessary flexibility to the network in response to
demands from the external environment and afferent inputs [4].
Among the wide family of neuromodulators, certain agents can
trigger locomotion, while others can speed it up or facilitate it in
concomitance with suitable stimuli [4]. Drugs in the latter category
are the most interesting, as they might be used to synergize
rehabilitation techniques that exploit the proprioceptive physio-
logical feedback [5,6] to restore post-lesion locomotor patterns
[7,8,9,10,11,12]. Unfortunately, the drugs tested so far have shown
contrasting results, underpinning the need for more efficient
conjoint strategies, using both afferent and pharmacological
stimulations [13]. However, in vitro studies have shown that
neuromodulators can differently affect the chemically and
electrically evoked fictive locomotion (FL) [14,15,16], indicating
the complexity of network targets.
The neuropeptide oxytocin is a nona-peptide endogenously
synthesized in the central nervous system, at the level of
hypothalamic nuclei, medial amygdale, locus coeruleus and
olfactory bulb [17]. In the spinal cord, oxytocin is exclusively
localized within axons [18] and the majority of oxytocin-
containing fibers originate from the hypothalamic paraventricular
nucleus (PVN) [19], as confirmed, in the rat, by the complete
disappearance of oxytocin after lesioning the PVN [20,21].
Moderate presence of oxytocin-containing fibers (but not cell
bodies) was confirmed in all laminae of the rat spinal cord, with
clear predominance in laminae I, II, VII and X [22,23] especially
at lumbar level [18].
Oxytocin, which during neonatal life plays a role as trophic or
differentiating factor during spinal cord maturation [23,24], serves
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as a neurotransmitter on receptors coupled to different G proteins
to mobilize intracellular Ca2+ and either open a non-specific
cationic channel or close a K+ channel [25]. The neuronal
distribution of oxytocin receptors (OTRs) parallels the distribution
of its fibers [26,27]. Oxytocin, on par with other neuropeptides,
does not seem to work directly on its target, but rather it appears to
have a neuromodulatory action in making it more responsive to
any incoming inputs [28]. Endogenous oxytocin concentrations in
the rodent cerebrospinal fluid (CSF) range from 15 to 80 pg/mL
[29], that is similar to values of the human neonatal CSF (20–
30 pg/mL) [30]. In the spinal cord, the overall content of oxytocin
is rather homogeneous (, 70 pg/mm of tissue), although three
times more oxytocin has been found in the first lumbar segments
[31], where the locomotor CPG is mainly localized [2].
Nonetheless, there are only few studies about oxytocin role in
the chemically-evoked locomotor network activity in vitro [32,33].
Thus, there are no data on the effects of oxytocin in integrating
afferent inputs into the CPG. The role of primary afferents in
modulating the locomotor pattern is linked to the existence of
sensory feedbacks evoked during gait to physiologically control, at
a pre-synaptic level, incoming inputs to the spinal cord [34], and
to convey facilitatory signals to the CPG via multisegmental
sacrocaudal afferents [35], even with nociceptive content [36].
An innovative protocol of electrical stimulation, characterized
by noisy waveforms and named FListim (Fictive Locomotion-
induced stimulation) [37], has recently demonstrated to generate
locomotor-like oscillations when delivered to a dorsal root (DR) or
to sacrocaudal afferents of the isolated spinal cord.
Compared to classic protocols of electrical stimulation, which
use trains of standard rectangular impulses [38], FListim requires a
much lower stimulation strength and induces locomotor-like
oscillations of longer duration [37]. Furthermore, FListim, as
opposed to trains of pulses traditionally delivered to dorsal
afferents, synergizes with sub-threshold concentrations of N-
methyl-D-aspartate (NMDA) and serotonin (5-hydroxytryptamine,
5HT) to activate the CPG [39]. Using the in vitro rat spinal cord,
the present study aims at exploring whether the neuropeptide
could facilitate the effects of FListims, comparing it with
chemically-evoked FL, and relating to its actions of synaptic
transmission, network rhythmicity induced by pharmacological
disinhibition [40] and motoneuron properties.
Methods
Spinal cord preparation and electrophysiological
recordings
All experiments involving the use of rats and the procedures
followed therein were approved by the Scuola Internazionale
Superiore di Studi Avanzati (SISSA) ethics committee and are in
accordance with the European Union guidelines. Animals were
maintained in accordance with the guidelines of the Italian Animal
Welfare Act. Spinal cords of neonatal Wistar rats (0 – 5 days old)
were isolated from the mid-thoracic segments to the cauda equine, as
previously described [41]. All efforts were made to minimize
number and suffering of animals used for the experiments.
After surgical dissection, each spinal cord was mounted in a
small recording chamber maintained at a constant room
temperature of 22uC and continuously superfused (5 mL/min)
with oxygenated (95% O2 and 5% CO2) Krebs solution,
composed as follows (in mM): 113 NaCl, 4.5 KCl, 1 MgCl2
7H2O, 2 CaCl2, 1 NaH2PO4, 25 NaHCO3, and 11 glucose,
pH 7.4.
For intracellular recordings, antidromically identified lumbar
(L4 or L5) motoneurons [42] were impaled using microelectrodes
filled with 3 M-KCl (30 – 40 MV resistance), in current-clamp
conditions. The input resistance of motoneurons was obtained by
delivering steps of current (amplitude from 20.8 to 0.8 nA,
duration = 80 ms). Current/voltage plots were linear within the
voltage range recorded and their slope indicates cell input
resistance. In control conditions, baseline input resistance and
membrane potential of motoneurons were, on average,
47.73619.50 MV (from 24.30 MV to 72.03 MV) and
265.7266.15 (n = 16), respectively.
Nerve recordings were performed in DC mode, using tight-
fitting suction electrodes, from the lumbar (L) ventral roots (VRs).
As a routine, recordings were obtained from the left (l) and right (r)
L2 VRs, which mainly convey flexor motor-pool signals to
hindlimb muscles, and from the l and r L5 VRs, principally
expressing extensor commands to the same hindlimbs [43].
Therefore, the characteristic alternation among the discharges
recorded from the flexor and extensor motor pools and between
the left and right sides of the cord proves activation of the
locomotor CPG. Signals were recorded, digitized and analyzed
adopting pClamp software (version 10.3; Molecular Devices, PA,
USA).
FL rhythm is elicited by the continuous bath application of
NMDA (1,5–5 mM; Tocris, Bristol, UK) plus 5HT (4–10 mM;
Sigma, Milan, Italy). Subthreshold pharmacological stimulation is
obtained by reducing the concentration of NMDA + 5HT to the
minimum required to induce a stable FL rhythm. To reduce the
synthesis of endogenous 5HT, several experiments were per-
formed where spinal cords were maintained overnight in Krebs
solution containing the tryptophan hydroxylase inhibitor, p-
chlorophenylalanine (PCPA, 10 mM; Sigma, Milan, Italy) in
accordance with Branchereau et al. [44]. On the following day
we recorded, in the continuous presence of PCPA, FL evoked by
NMDA (5 mM) plus 5HT (10 mM). Afterwards, oxytocin (100 nM
or 1 mM) was added to subthreshold concentrations of neuro-
chemicals as indicated earlier. Control sham preparations were
kept for the same period in Krebs solution, to confirm that
maintaining the spinal cord for 1 day in vitro does not change the
characteristics of chemically induced FL [45]. Longer in vitro
maintenance was not viable, since after 2 days in vitro, only 1 out
of 4 cords could express a brief episode of FL induced by NMDA
(5 mM) and 5HT (10 mM).
Out of a series of 19 experiments, we considered for analysis
only those which expressed stable FL after 10 min of continuous
superfusion with NMDA (5 mM) + 5HT (10 mM): that is, 6 cords
in Krebs solution and 9 in the group treated with PCPA (10 mM),
respectively.
A disinhibited bursting, that was synchronous among all VRs,
was produced by the pharmacological blockage of spinal
inhibition, mediated by GABAA and glycine receptors, with a
continuous bath-application of strychnine (1 mM; Tocris, Milano,
Italia) and bicuculline methiodide (20 mM; Abcam PLC, Cam-
bridge, UK). To validate the specificity of OTR activation,
atosiban was used at the same concentration that showed a
selective antagonism on in vitro experimental preparations of
neonatal rat central nervous system (5 mM) [46]. To reduce
synaptic input on motoneurons, the broad sodium channels
blocker, TTX (Abcam PLC, Cambridge, UK), was applied at the
concentration of 1 mM until electrically evoked antidromic spikes
fully disappeared (5 min). Afterwards, TTX was continuously
perfused at lower concentration (250 nM) to maintain sodium
current block throughout the experiment [47].
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Single or repetitive electrical stimulation of dorsal or
ventral roots
Single electrical pulses were applied to either DRs or VRs via a
bipolar suction electrode, in order to evoke either DR-DR
potentials (DR-DRPs) [48], DR-VR potentials from the homol-
ogous VR (DR-VRPs) or antidromic action potentials from single
motoneuron, respectively. Stimulus intensity was then calculated
in terms of threshold (Th = 11.3765.63 mA), which is defined as
the minimum intensity required to elicit a detectable response
from the homologous VR.
The stimulating protocol FListim (Fictive Locomotion-induced
stimulation) used corresponds to a 60 s segment of a chemically
induced FL recorded in AC mode from a VR, that was randomly
selected (range 0.1 Hz – 10 000 Hz; sampling rate = 500 Hz).
Through off-line analysis with Origin 9.0 software (OriginLab,
North Hampton, MA), the maximum current amplitude was
adjusted to pre-selected values, then the trace was exported (as an
ASCII text file) to a programmable stimulator (STG 4002; Multi
Channel Systems, Reutlingen, Germany). At last, FListim was
delivered to one DR, using a bipolar suction electrode, at an
optimal amplitude comprised within the range of
0.14460.0776Th. On the other hand, adopted intensities for
electrical subthreshold stimulation were considered equal to
0.09560.0696Th.
Analysis of rhythmic activity
Each FL rhythm was analyzed in terms of periodicity
(considered as the time between the onset of two consecutive
cycles) and amplitude (defined as the height of signals, expressed in
mV, calculated from the baseline at the beginning of each cycle to
its peak). Furthermore, regularity of rhythmic patterns was
expressed by the period coefficient of variation (CV; displayed as
standard deviation [SD] mean21). The strength of coupling
among pairs of VRs signals was defined by the cross-correlation
function (CCF) analysis. A CCF greater than + 0.5 indicates that
two roots are synchronous, while a CCF smaller than 2 0.5 shows
full alternation [49].
All parameters used for the definition of disinhibited bursting
and its measures (duration, cycle period, number and frequency of
intraburst oscillations) are in accordance with Bracci et al. [40].
Within each preparation and for each test conditions, at least 20
cycles of bursting were analyzed to average data.
All data are expressed as mean 6 S.D., where ‘‘n’’ indicates the
number of experiments. Before assessing statistical differences
among groups, a normality test was performed to select the use of
either parametric or non-parametric tests. Different statistical
approaches were used to compare sets of data. For parametric
values, the Student’s t-test (paired or unpaired) was used for
comparison between two groups of data and ANOVA (analysis of
variance), followed by post hoc analysis with Dunnett’s or Tukey
method for more than two groups. When referring to non-
parametric values, the tests used were Mann-Whitney or Wilcoxon
for comparing two groups and Kruskal-Wallis ANOVA on ranks,
followed by post hoc analysis with Dunn’s method, for a number
of groups greater than two. As for parametric data, one way
repeated ANOVA measures were used when each one of the cords
analyzed was exposed to more than two treatments. To assess the
success rates in inducing an episode of alternating oscillations by
weak FListims, plus increasing concentrations of oxytocin, with
respect to weak FListim alone, we applied the chi-squared test.
Collected results were considered significant when P,0.05.
Results
Nanomolar concentrations of oxytocin excite spinal
motoneurons
The example of Fig. 1 A, recorded from a motoneuron under
current clamp conditions, shows that, after 5 min application,
oxytocin (100 nM) depolarized the cell (plateau amplitude =
8.85 mV), with superimposed firing activity (2.14 Hz). The effects
of oxytocin waned after 30 min washout when a second exposure
to oxytocin induced similar depolarization (8.76 mV) and firing
(2.9 Hz). A longer perfusion (40 min) at a lower concentration
(1 nM, Fig. 1B) induced, after 8 min, the appearance of sporadic
bursts with superimposed action potentials, associated with
minimal change in baseline at steady state (3 mV) that persisted
through the entire application.
Two consecutive applications of oxytocin (1 mM, duration =
10 min), alternated with 20 min washout phases, were repeated on
the same cell (Fig. 1 C) and induced comparable depolarizations
(DV first application = 13.34 mV; DV last application =
13.12 mV). Thus, in our experiments, even at higher concentra-
tions, no desensitization appeared when applications of oxytocin
were spaced out by at least 20 min.
The average cumulative dose-response curve (Fig. 1 D),
obtained from different (3–10) motoneurons, had a shallow slope
extending over a 0.5–1000 nM range (EC50 of 72 nM). Fig. 1 D
also shows that, for each concentration of oxytocin, there was no
change in input resistance at rest (filled triangles; one way
ANOVA on raw data; P = 0.995; n = 3–4). Hence, these results
suggested that the depolarizing effect of oxytocin had a mainly
indirect origin. We corroborated this hypothesis by performing
experiments in the presence of tetrodotoxin (TTX; 250 nM) to
block network synaptic transmission, in analogy with our former
study [47]: the example in Fig. 1 E indicates absence of
motoneuron depolarization under this condition, without any
change in the frequency of miniature post synaptic potentials
(1.1760.24 Hz vs 1.0860.07 in control TTX solution). Thus, the
most likely explanation is that the depolarization mediated by
oxytocin was not evoked by the direct action on motoneuron
membrane, but it arose from the activation of a premotoneuron
network.
Network effects of oxytocin
Extracellular recordings from several VRs expressing the
discharge of motoneuron pools and their premotoneuron circuitry
(as exemplified in Fig. 2 A) showed strong network activity induced
by oxytocin (100 nM) consisting in an initial VR depolarization on
both sides of the cord, reaching (after 2 min) a maximal peak of
0.5060.25 mV (average data from the four recorded VRs) versus
the control baseline. After 6 min of continuous application, VR
depolarization declined to a stable value (0.3160.19 mV) versus
the control baseline before oxytocin application. During the initial
depolarization, irregular VR activity emerged together with bursts
(synchronous among all VRs; Fig. 2 B), which eventually faded
away.
In a series of six preparations, for each spinal cord, the steady
state depolarization induced by 100 nM oxytocin on each VR was
recorded and averaged among the four roots to provide the
datapoints used to construct the histogram shown in Fig. 2C
(0.3360.20 mV).
We next explored whether the network effects induced by
oxytocin were associated to any change in reflex activity. One
representative experiment is shown in Fig. 3 A, B in which we
averaged five consecutive Dorsal Root-evoked Ventral Root
Potentials (DR-VRPs) elicited on one lumbar VR by weak (A) or
Neuropeptide Synergism
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strong (B) electrical pulses (gray arrows). When weak DR stimuli
(intensity = 10 mA, Th, 16Th) were used to activate low
threshold afferent fibers, 100 nM oxytocin induced a reversible
depression of DR-VRPs (Fig. 3 A), as confirmed by the mean
values pooled from five spinal cords (Fig. 3 C). On the other hand,
at a higher stimulating strength (36Th), the same oxytocin
concentration (100 nM) did not produce any significant change in
peak and area of polysynaptic responses (Fig. 3 B middle), while
only a 10-fold larger concentration (1 mM) did depress reflexes
(Fig. 3 B right). On average, at higher intensities of stimulation,
concentrations of oxytocin up to 100 nM did not change DR-
VRPs (Fig. 3 D), while a significant decrease (by 20 – 25% vs
control) in peak reflex amplitude was detected at 200 nM and
1 mM oxytocin.
Augmenting concentrations of oxytocin speeded up the
disinhibited rhythm by acting selectively on oxytocin
receptors
The emergence of irregular bursts during oxytocin application
suggested that this neuropeptide could trigger, albeit for a short
time, the intrinsic rhythmicity manifested as synchronous
discharges from VRs. To further explore this issue, we examined
how oxytocin could affect the spontaneous bursting of spinal
networks, which appears when spinal inhibition mediated by
GABAA and glycine receptors is blocked by strychnine (1 mM) and
bicuculline (20 mM) and requires a minimal circuitry restricted to a
ventral quadrant of the spinal cord [40].
In the example of Fig. 4 A, a stable disinhibited rhythm (top
trace) was speeded up by 5 nM oxytocin, without changing burst
Figure 1. Oxytocin indirectly depolarizes single motoneurons. A, intracellular recording from a single motoneuron (lL4) shows that, after
5 min, oxytocin (100 nM; see gray bars) depolarises membrane potential and evokes high frequency spiking. Initial resting potential (Vm) is 270 mV.
B, lower concentration of oxytocin (1 nM; see bar) determines a slower (8 min) onset of bursts with intense firing activity despite minimal baseline
depolarization that persists throughout the long neuropeptide perfusion (40 min). Initial resting potential is 275 mV. Note that the 10 min trace
break corresponds to the time spent in generating tests for the cell I/V curve. Different cell from A. C, two consecutive applications of oxytocin (1 mM)
induce reproducible responses when timed 20 min apart. Initial resting potential is 269 mV. Different cell from A, B. D, dose response plots of
membrane potential depolarization (from baseline; fitted with sigmoidal curve; filled circles) and input resistance (as percentage value with respect to
control; gray triangles) for cumulative doses of oxytocin (log scale). Symbols *, 1 indicate significant difference versus the higher concentrations data
(Kruskal-Wallis one way ANOVA on ranks followed by all pairwise multiple comparison with Dunn’s method; P,0.001; the number of preparations
used to calculate the mean is shown in parentheses; the error bars indicate SD). E, sample trace from a single motoneuron (lL5) demonstrates that
oxytocin (100 nM) fails to depolarize the cell when applied (see arrow) in the presence of network block by TTX (250 nM; gray bar).
doi:10.1371/journal.pone.0092967.g001
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amplitude. On the same preparation, further increases in rhythm
frequency were obtained with 100 nM or 1 mM oxytocin. The
cumulative dose-response curve in Fig. 4 B reports a dose-
dependent reduction in the mean period (expressed as a percent of
control) for increasing concentrations of oxytocin (0.5 nM –
10 mM), with an IC50 of 55 nM (n = 3–6) with an effect saturation
amounting to circa 60% acceleration. Oxytocin did not signifi-
cantly modify burst amplitude (gray triangles in Fig. 4 B; Kruskal-
Wallis one way ANOVA, P = 0.961, n = 3–6) and bursting
regularity (calculated as CV value; one way ANOVA, P = 0.300,
n = 3–6).
The structure of single disinhibited bursts was altered by the
addition of the neuropeptide. In particular, despite an unchanged
first phase of depolarizing plateau (one way ANOVA, P = 0.117,
n = 9), the total duration of the single burst was reduced (one way
ANOVA, P = 0.021, n = 3–6), along with faster intraburst
oscillations (one way ANOVA, P = 0.034, n = 3–6), while their
number remained unaffected (one way ANOVA, P = 0.765, n = 3–
6).
In the presence of strychnine and bicuculline, oxytocin
(100 nM) slowly depolarized VRs with a plateau (10 min) of
0.7760.10 mV (n = 3), which did not statistically differ from the
depolarization elicited by the neuropeptide in control conditions
(t-test, P = 0.355).
The effects of oxytocin were mediated by OTRs as demon-
strated by applying the selective pharmacological antagonist,
atosiban (5 mM) that (as shown in Fig. 4 C), without modifying per
se rhythm features, fully prevented burst acceleration and VR
depolarization by 100 nM oxytocin. This observation suggests that
OTRs are not endogenously activated during disinhibited rhythm,
yet mediate the action of exogenously-applied oxytocin. The
histograms in Fig. 4 D summarize the average values of bursting
periodicity obtained from 4–6 experiments. While oxytocin
(100 nM) significantly reduced the period (black bar), there was
no significant variation with atosiban (5 mM) alone or of atosiban
plus oxytocin. These results are consistent with an action by
oxytocin on spinal networks accessory to the rhythmic ones and
capable of modulating intrinsic rhythmicity.
Neither oxytocin nor atosiban altered frequency and
regularity of oscillations of the chemically evoked fictive
locomotion
The discrete effects by oxytocin on spontaneous bursting
prompted further experiments to find out if the peptide could
Figure 2. Oxytocin induces VR rhythmic activity. The application
of 100 nM of oxytocin (gray bar) depolarizes bilateral VRs at L2 and L5
levels (A). The early phase of VR depolarization is associated with bursts
synchronous among all roots, followed by a partial repolarization. B, the
rhythmic activity evoked by oxytocin on the four VRs shown in A (gray
bar) is displayed, on a faster time scale, to depict synchronous bursts
composed of apparently unrelated, fast intraburst oscillations. Histo-
gram (C) illustrates, for each spinal cord, the average depolarization
(recorded from 4 VRs) induced by oxytocin 100 nM, while the gray bar
shows the mean value of all experiments. All vertical bars are 200 mV.
doi:10.1371/journal.pone.0092967.g002 Figure 3. Oxytocin differentially affects DR-VRPs. A, the
monosynaptic response elicited by stimulating the homologous DR at
just threshold intensity (duration = 0.1 ms; intensity = 15 mA, 16Th) is
significantly depressed by the addition of 100 nM of oxytocin, an effect
that partially reversed after 20 min washout. B, DR-VRPs, extracellularly
recorded from VRlL5, are evoked by strong electrical stimulation of the
homologous DR (duration = 0.1 ms; intensity = 45 mA, 36Th; arrows)
in control (left), or after applying oxytocin 100 nM (middle) and 1 mM
(right). Note records in B are shown on a slower time base to display the
secondary component of polysynaptic DR-VRP and, therefore, hide the
stimulus artifact. Only the highest tested concentration of the
neuropeptide is able to reduce the peak of reflex response. Traces in
A and B are mean values from five events and are obtained from
different spinal cords. Histograms (C) show summary of responses to
low strength of stimulation (16Th) with significant reduction in the
percentage peak obtained from 5 experiments (*; Mann-Whitney rank
sum test; P = 0.016). D shows the average percentage variation in peak
amplitude of DR-VRPs (with respect to control) evoked by strong stimuli
(36Th), against cumulative increase in oxytocin concentrations. Only
the higher concentrations (0.2–1 mM) significantly depress responses (*;
Kruskal-Wallis one way ANOVA on ranks followed by multiple
comparison vs WASH with Dunn’s method; P = 0.004, the number of
preparations used to calculate the mean is shown in parentheses; the
error bars indicate SD).
doi:10.1371/journal.pone.0092967.g003
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modulate locomotor-like oscillations that require a more complex
pattern of rhythmic activity including reciprocal inhibition [1].
Fig. 5 A shows (on a slow time base) a stable FL rhythm evoked by
5 mM of NMDA and 10 mM of 5HT (open horizontal bar). On a
faster time base, a sample of this record clearly demonstrates the
characteristic double alternation of FL cycles recorded from L2
and L5 VRs on both sides of the cord (Fig. 5 B). Addition of
100 nM oxytocin (gray bar in Fig. 5 A) depolarized VRs
(0.2760.06 mV average from four VRs) and reduced the
amplitude of locomotor cycles, without modifying frequency or
regularity of rhythm (Fig. 5 C). The same observation was
repeated with a random sample of 9 experiments, that gave an
average depolarization of 0.3560.22 mV, not statistically different
from the depolarization elicited by oxytocin (100 nM) in control
conditions (t-test, P = 0.284).
Oxytocin (100 nM) did not modify period (paired t-test,
P = 0.054, n = 13) or regularity (Wilcoxon signed rank test,
P = 0,094, n = 13) of FL rhythm, while the amplitude of FL
oscillations was significantly reduced in each preparation (Fig. 5
D).
Additional experiments were performed in order to verify
whether higher doses of oxytocin could vary any of the rhythm
parameters unaffected by 100 nM oxytocin. In five spinal cords,
on which oxytocin was tested at 100 nM and 1 mM during a stable
FL, period or CV values were not statistically different for either
concentrations (one way repeated measures ANOVA, P = 0.808
and P = 0.927, respectively), while cycle amplitude was equally
reduced by either concentrations with respect to their control
(Fig. 5 E; one way repeated measures ANOVA followed by all
pairwise multiple comparison procedures with Tukey test,
P = 0.004). Finally, as demonstrated with the example of Fig. S1,
the oxytocin receptor antagonist atosiban (5 mM) applied together
with NMDA (5 mM) and 5HT (10 mM) did not change FL. On
average, on 6 spinal cords, the addition of atosiban (5 mM) to a
stable FL rhythm induced by NMDA and 5HT did not depolarize
VRs (0.2060.45 mV), nor did it modify period (3.5661.09 s in
ctrl vs. 3.8660.53 s plus atosiban; paired t-test, P = 0.606),
regularity of alternating oscillations (Wilcoxon signed rank test,
P = 0.563) or cycle amplitude (Wilcoxon signed rank test,
P = 0.688).
Figure 4. Disinhibited bursting is accelerated by oxytocin, an effect prevented by its selective antagonist. A, regular disinhibited
rhythm induced by 1 mM strychnine and 20 mM bicuculline (top trace in A) is stably sped up (with burst length reduction) by the cumulative addition
of oxytocin (5, 100 nM and 1 mM), without any further modifications in the characteristics of single bursts. The cumulative dose response curve in B
indicates significant reduction in the average period (expressed as a percentage of the mean variation), starting at concentration of 5 nM (*; one way
ANOVA followed by multiple comparison vs strychnine + bicuculline only with Dunnett’s method; P =,0.001; the number of preparations used to
calculate the mean is shown in parentheses; the error bars indicate SD). C, on a different preparation, a stable disinhibited rhythm (top) remains
unchanged by the addition of the OTRs antagonist, atosiban (5 mM, middle), which prevents any acceleration during the following addition of
oxytocin (100 nM). The histograms in D, which report the average value of period of disinhibited rhythm in correspondence to the different
treatments, show significant rhythm acceleration in the presence of oxytocin (100 nM), an effect reverted to control values after washout (30 min),
and prevented by the addition of atosiban (5 nM), which does not per se vary rhythm periodicity (*; Kruskal-Wallis one way ANOVA on ranks followed
by multiple comparison vs strychnine + bicuculline only with Dunn’s method; P = 0,038; the number of preparations used to calculate the mean is
shown in parentheses; the error bars indicate SD).
doi:10.1371/journal.pone.0092967.g004
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Synergy between oxytocin and NMDA plus 5HT in
eliciting FL
Although OTRs did not physiologically control chemically-
induced FL, we explored whether the accelerating property shown
by this neuropeptide could be exploited to facilitate the activation
of locomotor circuits. For this reason a stable FL was first induced
using the lowest effective concentrations of NMDA and 5HT
(Fig. 6 A). Afterwards, the concentration of neurochemicals was
decreased to slow down rhythm period (Fig. 6 B), and eventually to
replace FL with a mere irregular activity (Fig. 6 C). Doses of
oxytocin as low as 1 nM were not able to re-establish alternating
discharges (Fig. 6 D). However, by combining the application of
oxytocin (100 nM) with low concentrations of neurochemicals,
stable locomotor oscillations reappeared (Fig. 6 E). A further
increase in oxytocin concentrations did not modify the features of
the reinstated FL (Fig. 6 F).
Similar experiments were repeated with 12 preparations, in
which 100 nM oxytocin in the presence of subthreshold concen-
trations of neurochemicals induced a FL similar to control for
mean period, period CV and cycle amplitude (Table S1
summarizes these data). To explore the possibility that an increase
in oxytocin might change any of the parameters related to the
rhythm rescued by 100 nM oxytocin, we cumulatively added
1 mM oxytocin to subthreshold concentrations of neurochemicals.
On average, neither periodicity (one way repeated measures
ANOVA, P = 0.313, n = 3), regularity (one way repeated measures
ANOVA, P = 0.232, n = 3) nor cycle amplitude (one way repeated
measures ANOVA, P = 0.296, n = 3) were further affected. Finally,
in five experiments, oxytocin applied within the concentration of
1–50 nM was unable to activate a subthreshold FL.
Oxytocin facilitation of fictive locomotor patterns
requires endogenous 5HT synthesis
Since OTRs are reported to modulate the release of 5HT
[50,51] that largely contributes to FL [52], it seemed likely that
oxytocin-mediated increase in endogenous 5HT release contrib-
uted to bring FL patterns to threshold. To explore this hypothesis,
we performed experiments in which the isolated spinal cord was
treated overnight with the inhibitor of the tryptophan hydroxylase,
p-chlorophenylalanine (PCPA, 10 mM), with the aim of reducing
the synthesis of endogenous 5HT. Fig. 7 shows two typical
experiments run in parallel, in which two different spinal cords
were kept overnight in a Krebs (A) or PCPA (10 mM; B) solution,
respectively. On the second day, in the presence of NMDA (5 mM)
and 5HT (10 mM), both preparations displayed a stable FL (Fig. 7
A,B, left panels). On average, all cords tested the day after, showed
a FL period of 2.9861.22 s (CV = 0.1260.04; n = 15), without any
significant difference between the sham group and the one treated
with PCPA (t-test, P = 0.843, n = 6–9).
After washout (20 min), preparations were first perfused with
subthreshold concentrations of neurochemicals (Fig. 7 A,B, second
panels) to which 100 nM oxytocin was subsequently added (Fig. 7
A,B) without emergence of any FL. In the example depicted in
Fig. 7 A (right), further increase in oxytocin concentration (1 mM)
triggered a stable FL similar to control for period (90% of control),
CV (0.12 vs 0.15 in control) and amplitude (90% of control)
values. This observation was replicated in three out of four sham
spinal cords, as 1 mM oxytocin re-established the FL rhythm with
regularity (CV period = 0.12), period (paired t-test, P = 0.266,
n = 3) and amplitude (paired t-test, P = 0.669, n = 3) comparable to
those induced on the same preparations by NMDA (5 mM) and
5HT (10 mM). On the contrary, in all preparations treated with
PCPA (10 mM), as exemplified in Fig. 7 B, oxytocin at 100 nM (9/
9) or 1 mM (7/7) concentration never triggered FL in the presence
of subthreshold NMDA and 5HT, even if these preparations
displayed control patterns with NMDA (5 mM) plus 5HT (10 mM).
Figure 5. Oxytocin decreases cycle amplitude of FL without
changing periodicity. A, a stable FL is induced by the application of
5 mM NMDA and 10 mM 5HT. A sample of traces, corresponding to the
gray bar in the bottom-left, shows, on a faster time base, the
characteristic double alternation among L2 and L5 homosegmental
and homolateral VRs (B). Addition of oxytocin (100 nM; see gray bar in
A, top) depolarizes all VRs. As depicted in the insert corresponding to
the gray bar in the bottom-right of A, in the presence of oxytocin
oscillations maintain their typical double alternation, although with
smaller amplitude. The scatter plot in D reports the single values of
cycle amplitude for different experiments (gray dots and lines), pointing
out the significant reduction in average amplitude of oscillations (open
bars) after the addition of oxytocin (0.2260.15 and 0.1860.13 mV,
respectively; *; paired t-test; P = 0,001; n = 13). Histograms in E depict
the reduction in amplitude of FL oscillations in correspondence to
cumulative increase in oxytocin concentrations (100 nM and 1 mM) that
are equally able to reduce cycle amplitude with respect to control (*,
one way repeated measures ANOVA followed by all pairwise multiple
comparison procedures with Tukey test, P = 0.004, n = 5).
doi:10.1371/journal.pone.0092967.g005
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Nanomolar concentrations of oxytocin synergize with the
delivery of innovative protocols of low intensity electrical
stimulation
The novel FListim protocol of DR electrical stimulation based
on capturing the FL cycles and applying them to one DR, has
been shown to optimally activate the in vitro CPG much more
effectively than standard trains of DR pulses: the resulting rhythm
shows, however, stereotypic periodicity [37].
The present study investigated whether oxytocin could syner-
gize with a subthreshold FListim. Fig. 8 shows one example taken
from the same preparation tested with various protocols. Thus, the
FListim protocol (duration = 60 s, intensity = 0.26Th) [37,39]
was first applied to a sacral DR, inducing a cumulative
depolarization with superimposed an episode of alternating cycles
on L2 and L5 VRs (on both sides), lasting throughout the delivery
of the stimulating pattern (Fig. 8 A). At the same strength of
stimulation, alternating oscillations evoked by FListim were not
statistically modified by the conjoint application of oxytocin (1 –
100 nM; not shown).
By lowering the strength of FListim (0.16Th), the resulting
cumulative depolarization was smaller with sporadic oscillations,
synchronous among all VRs (Fig. 8 B). Nevertheless, applying the
lowest tested concentration of oxytocin (1 nM), the weak FListim
was now able to evoke a cumulative depolarization (0.97 mV) with
a superimposed episode of FL (Fig. 8 C), comparable to the one
recorded in control with FListim delivered at optimal amplitude
(0.26Th; Fig. 8 A). However, increasing oxytocin up to 100 nM
(to induce 0.96 mV cumulative depolarization per se) together with
FListim at 0.16Th failed to elicit a FL (Fig. 8 D).
The cross-correlograms on the pair of homosegmental VRs at
L2 level for the three protocols are superimposed in Fig. 8 E to
assess cycle alternation. Thus, the negative peak centred around
zero lag during the coapplication of 0.16Th FListim plus oxytocin
1 nM (red trace) confirms FL pattern comparable to the one
evoked by FListim at 0.26Th (blue trace), while the plot for
0.16Th FListim alone yielded a flat trace (black), indicating
uncorrelated activity.
In eight experiments, oxytocin (1 nM) in combination with a
weak FListim, always triggered the onset of FL as much as a
stronger FListim did. Conversely, the probability to induce FL fell
with stepwise increase in oxytocin concentrations, while keeping
the same weak FListim (Fig. 8 F) without variation in the
amplitude of cumulative depolarization (Kruskal Wallis one way
ANOVA on ranks followed by post hoc analysis with Dunn’s
method, P = 0.286; n = 8).
One component of the oxytocin complex action on FListim
might have comprised dose-dependent modulation of pre-synaptic
inhibition on afferent inputs investigated as reported by Hochman
et al. [53]. Thus, experiments were performed in which dorsal root
potentials were recorded in response to electrical stimulation of the
adjacent dorsal root (DR-DRPs), at both low and high pulse
strength (Fig. S2 A, B). In the presence of oxytocin (1 or 100 nM),
no differences were observed in the peak amplitude of DR-DRPs,
at either low (Fig. S2 C) or high (Fig. S2 D) intensity, or in the area
recorded with the high-strength stimulation (Fig. S2 E). These
results show that the enhancement in post-synaptic responses
Figure 6. Oxytocin reinstates fictive locomotor oscillations, despite subthreshold concentrations of neurochemicals. Alternating
oscillations of a stable FL, evoked by the addition of 3 mM NMDA and 10 mM 5HT (A), slow down once the concentration of neurochemicals is finely
titrated down to 1.7 mM NMDA and 5 mM 5HT (B). A further decrease in NMDA (1.5 mM) + 5HT (4 mM) suppresses locomotor-like discharges, which are
finally replaced by a tonic activity (C). By adding oxytocin (1 nM) to subthreshold concentrations of NMDA and 5HT, no FL oscillations reappear (D). By
augmenting the neuropeptide to 100 nM, locomotor-like oscillations are restored (E). Further increase in oxytocin (1 mM) does not affect periodicity
of the reinstated pattern nor its cycle amplitude (F).
doi:10.1371/journal.pone.0092967.g006
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generated by the downstream motor networks after application of
oxytocin, was not accompanied by any detectable modulation of
pre-synaptic inhibition on primary afferent signals.
Discussion
The present study analyses the complex effects evoked by
oxytocin in modulating the basal characteristics of single
motoneurons, the synaptic responses induced by afferent stimu-
lation, and two different types of locomotor network activity.
Although these data were collected from the in vitro mammal spinal
cord, they can help to interpret the functional impact of oxytocin
targets on spinal circuits and emphasize how even nanomolar
concentrations of this neuropeptide could synergize with innova-
tive stimulation protocols to elicit locomotor network activation.
Facilitatory effects by oxytocin
While application of oxytocin per se never elicited FL in line with
previous observations [32,33], the peptide did evoke a number of
responses that ranged from dose-related motoneuron depolariza-
tion (lacking change in input resistance) with repetitive or burst
firing, VR depolarization associated with synchronous discharges,
and acceleration of disinhibited bursting (with burst length
reduction). All these effects were persistent and showed no
tachyphylaxis. When network activity was blocked by TTX to
minimize spike-dependent neurotransmission [54], inhibition of
oxytocin responses was observed in accordance with a previous
study [55]. In slices of neonatal rat spinal cords, no depolarization
of motoneurons is observed, indicating that a substantial multi-
segmental network is a prerequisite for observing these responses
[23,56]. These results suggest that most (if not all) of these actions
were likely exerted at premotoneuron level. This notion is
consistent with the description of sparse oxytocin-containing fibers
contacting motoneurons [57] and lack of evidence supporting the
expression of OTRs by motoneurons [23,26,27,58]. Despite the
report of a subpopulation of glycinergic dorsal interneurons with
OTR [23], the present data obtained with strychnine and
bicuculline application suggest that the activation of such
interneurons is not mandatory to produce these stimulatory
effects. Future studies are necessary to identify the precise
premotoneuron elements responsible for the observed effects by
oxytocin in analogy with the approach used to dissect out the
mechanism of action of dopamine to stabilize FL and excite
motoneurons [59].
Oxytocin-mediated modulation of synaptic responses
Unlike the facilitatory effects produced by oxytocin on the basal
activity of spinal circuits, oxytocin elicited more complex responses
when such spinal networks were electrically or chemically
stimulated. Although low nanomolar concentrations of the peptide
had no significant action on reflexes, at concentrations $ 100 nM
oxytocin significantly depressed DR-VRPs (see also [60]), espe-
cially those evoked by weak stimuli. Since OTRs are not expressed
by afferent fibers [61], the observed changes in synaptic
transmission were probably generated within spinal networks.
Assuming that one important factor determining the size of the
DR-VRP is the extent of the activated premotoneuron circuitry in
turn related to the electrical pulse strength, the present results
suggests that the depressant action of oxytocin was dependent on
the activation state of network elements. This suggestion was
Figure 7. Inhibitor of endogenous 5HT synthesis prevents facilitation by oxytocin of FL. Two different preparations are maintained
overnight in Krebs solution, upper traces (A), or in the presence of the inhibitor of 5HT synthesis (PCPA, 10 mM; lower traces, light gray field, B),
respectively. On the following day, in both preparations, a stable FL is recorded in the presence of NMDA (5 mM) plus 5HT (10 mM; A, B, left). By
decreasing the concentration of neurochemicals, alternating oscillations are replaced by a tonic activity with slow depolarizing events, apparently
unrelated among different VRs (A, B, second panels). The addition of oxytocin (100 nM) to subthreshold concentrations of NMDA and 5HT fails to
reinstate FL (A, B, third panels). However, further increase in oxytocin to 1 mM induces reappearance of a stable FL only in the preparation maintained
in Krebs solution (A, right), while, in the one incubated with PCPA, no alternating oscillations are observed (B, right). Note that PCPA (10 mM) is
continuously perfused during all different experimental phases conducted on the spinal cords treated in PCPA overnight (B).
doi:10.1371/journal.pone.0092967.g007
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further explored by studying how a function-related network
rhythm of the CPG was modulated by the peptide.
Oxytocin facilitates the expression of the locomotor
pattern
Despite its inhibitory effects on reflex activity, oxytocin ($
100 nM) showed functional synergy with NMDA and 5HT in
triggering oscillations when the CPG activity was subthreshold
[32,33]. When locomotor networks were fully activated by NMDA
and 5HT to express strong neuronal discharges alternating among
distributed motor pools [62], 100 nM oxytocin unexpectedly failed
to up or downregulate FL, suggesting that either any reflex
depression was restricted to certain pathways not essential for FL
(albeit impinging on motoneurons), and/or that the degree of
neuronal activation by NMDA and 5HT was large enough to
overwhelm oxytocin-mediated decrease in synaptic transmission.
This view is consistent with the lack of effects by the OTR
antagonist atosiban on a stable FL pattern.
The precise mechanism responsible for these divergent effects
by oxytocin remains unclear. Nevertheless, similar effects were also
observed with extracellular recordings from rat dorsal horn
neurons in vivo with half of them being inhibited and the rest
being activated by focally applied oxytocin, suggesting activation
of inhibitory interneurons upstream of excitatory neurons [63].
While these in vivo results preclude the possibility of in vitro
artefacts, various hypotheses might be advanced to account for the
action of oxytocin on locomotor networks. In fact, although the
spinal locomotor networks include distributed neuronal elements
as indicated by functional labelling experiments [64], the
expression of OTRs by lamina X neurons [27], that comprise
commissural cells suitable to generate adaptable inputs to fine tune
locomotor outputs [65], appears to link the effects of oxytocin to
the pattern-generating networks.
A potential mechanism for the facilitatory role played by
oxytocin might reside in the reported enhancement of endogenous
5HT release [50,51] because this biogenic amine is well-known to
potently modulate locomotor-like activity [52]. To test this notion
in the present study, 5HT synthesis was inhibited by overnight
incubation with PCPA [44] and fully prevented any facilitatory
action by oxytocin on the locomotor CPG. Nevertheless, because
5HT receptors include a large family of subtypes [66] with
multiple effects and even functionally-distinct targets in the rat
spinal cord [67,68,69], it is proposed that the functional outcome
of the oxytocin action might be related to where and how
extensively endogenous 5HT was concurrently liberated. In
addition, as oxytocin positively modulates AMPA receptor-
dependent transmission in a subpopulation of neurons only [70],
location and synaptic contact topography of such neurons may
determine the expression of oxytocin action.
A further possibility to account for the multifarious effects by
oxytocin relies on the peculiar characteristics of its G-protein
coupled receptors that can be coupled to different G-proteins
(activating divergent intracellular signalling pathways). These
receptors are often promiscuous, as a single receptor subtype
may couple to more than one G-protein, thus activating, in the
same cells, multiple responses at the same time [71,72]. Moreover,
OTR may cluster together to produce functional oligodimers
whose assembly and signalling strength depends on the agonist
concentration with differential results in terms of functional
responses [71,73]. Through a combination of these properties,
oxytocin may show different potency/efficacy via different
signalling pathways activated by the same receptor, in analogy
with a multistate model of receptor activation [72].
Figure 8. Low nanomolar concentrations of oxytocin synergize
with FListim in expressing fictive locomotor patterns. A, FListim
(0.26Th) generates cumulative depolarization with alternating oscilla-
tions among homolateral L2 and L5 VRs and among controlateral
homosegmental VRs. When stimulus intensity is halved (0.16Th), a
slight cumulative depolarization with synchronous discharges (time
locked with the stimulating pattern) appears among all VRs (B). Despite
the weak electrical stimulation (FListim 0.16Th), the addition of low
concentration of oxytocin (1 nM) re-establishes cumulative depolariza-
tion and FL cycles (C). Increased concentration of oxytocin (100 nM)
fails to synergize with the same FListim 0.16Th (D). Cross correlation
analysis for traces related to the pair of L2 VRs in A–C shows a negative
peak centered around zero lag for suprathreshold FListim (blue trace) or
subthreshold FListim plus 1 nM oxytocin (red trace). The weak FListim
alone (black trace) has a CCF value close to zero, corresponding to an
uncorrelated activity among the two VRs (E). F, histograms show that,
by increasing the concentration of oxytocin, the probability of bringing
FL to threshold with a weak FListim diminishes in a dose dependent
manner (*; Chi-square vs FListim 0.16Th alone; P = 0.005; n = 8).
doi:10.1371/journal.pone.0092967.g008
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Oxytocin synergizes with stimulation by weak noisy
waveforms
There were several analogies in the effects by oxytocin on FL
evoked by chemical agents or by FListim. In the present
experiments, oxytocin facilitated the emergence of FL in the
presence of a train of weak FListim per se unable to elicit persistent
alternating patterns. The probability of triggering FL depended on
the oxytocin concentration, i.e. when it was low, a high probability
of success emerged, conversely with high concentrations it was
more difficult to induce FL. It is noteworthy that the most
favourable outcome therefore implied weak FListim and low
oxytocin, a paradigm that, at least in theory if applied in vivo,
should be the less prone to evoke unwanted side effects cause by
peripheral action of oxytocin or local dysfunction by application of
strong current pulses. The only apparent difference of this
paradigm against FL caused by NMDA and 5HT was the
effective concentration range of oxytocin that was optimal at small
doses found to be ineffective on chemically-induced FL. It should
be borne in mind that FListim requires repeated activation of
dorsal afferents and that any reflex-depressant action by larger
doses of oxytocin would probably have a negative impact on
efficient signalling to attain CPG activation. This problem would
be circumvented by chemical FL as afferent fibres are not
concomitantly stimulated because the locomotor CPG displays a
modular organization, whereby different inputs may activate
subpopulations of interneurons, that only partially overlap [62,74].
The synergy between weak FListim and low oxytocin indicated
an interesting protocol whereby FListim, due to the low
stimulation intensities used, might represent a signal to activate
only a network subpopulation crucial for the expression of FL,
unlike the more generalized activation obtained with neurochem-
icals, which inevitably recruits many other spinal interneurons,
some of which even unrelated to locomotion [62]. The most
parsimonious hypothesis of the observed synergy is that a discrete
distribution of OTRs with intrinsic properties (like affinity or
intracellular effector coupling) might be found on certain network
elements that selectively contribute to the expression of FL.
Conclusions
Due to the well defined sensory input through DRs and motor
output through VRs, the isolated neonatal rodent spinal cord
represents a suitable model to investigate innovative protocols of
afferent stimulation able to optimally activate the spinal interneu-
ronal network [75]. The combination of intra and extracellular
recordings, associated with the direct application of selective
pharmacological protocols for inducing different types of rhythmic
activity, allowed us to postulate that OTRs are strategically located
on locomotor circuit nodes whose activation is necessary to
propagate and recruit the CPG operation.
Current interest in the central effects of oxytocin includes
clinical trials of this peptide for schizophrenia or learning disorders
[25]. The wide gap between these disorders points a broad role of
the neuropeptide in modulating central networks and its overall
safety in man. Thus, the present data may add a further hint to test
low doses of oxytocin in combination with direct electrical
stimulation of the spinal cord [5,76] in exploiting the residual
locomotor capacities after spinal damage. In conclusion, our
results appear interesting when considering ongoing clinical trials
targeting oxytocin for spinal cord dysfunction (http://clinicaltrials.
gov).
Supporting Information
Figure S1 Endogenous oxytocin does not modulate locomotor
patterns. A, a stable FL is recorded in response to the co-
application of NMDA (5 mM) and 5HT (10 mM). The addition of
the selective antagonist for OTRs (atosiban, 5 mM) does not alter
periodicity of FL rhythm or amplitude of oscillations.
(TIF)
Figure S2 DR-DRPs are unaffected by oxytocin. Depolarizing
potentials are recorded from DRlL5 following electric stimulation
of the controlateral DR by a series of single pulses (duration =
0.1 ms, 0.016 Hz). A, average DR-DRP evoked by low- strength
stimulation (16Th) is unchanged by increasing concentrations of
oxytocin (1 nM, middle; 100 nM, right). Note the artefact of
stimulation as indicated by arrows. On the same preparation, by
augmenting the pulse strength (delivered as indicated by the
arrows) to evoke larger and longer DRPs, no significant change is
induced by this neuropeptide (B). Traces in A and B are mean of
five responses. Histograms for the mean values obtained from four
experiments, demonstrate that the addition of oxytocin, at both
100 nM and 1 mM, does not alter peak of DR-DRPs evoked at
lower strength (C; one way repeated measures ANOVA,
P = 0.155, n = 4), or peak (D; one way repeated measures
ANOVA, P = 0.392, n = 4) and area (E; one way repeated
measures ANOVA, P = 0.306, n = 4) of responses at the higher
strength of stimulation.
(TIF)
Table S1 Characteristics of FL patterns induced by NMDA +
5HT or in the presence of subthreshold concentrations of
neurochemicals + oxytocin.
(DOC)
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